Publications by authors named "Emma Louise Malchau Carlsen"

Group B Streptococcus (GBS) disease in neonates occurs in two forms: early-onset disease (EOD), (day 0-6), and late-onset disease (LOD), (day 7-90). This review investigates that risk-based intrapartum screening and antibiotics have reduced the incidence of EOD, but not LOD, in Denmark. No clinical or laboratory tests can rule out GBS disease at symptom onset.

View Article and Find Full Text PDF

Background: Families with an infant in need of intensive care most often experience a harmful separation after birth. This is due to a division of medical specialties into neonatal care and maternal care. Therefore, a couplet care intervention is implemented for mother-infant dyads in a neonatal intensive care unit.

View Article and Find Full Text PDF

Early diagnosis of infections in young infants remains a clinical challenge. Young infants are particularly vulnerable to infection, and it is often difficult to clinically distinguish between bacterial and viral infections. Urinary tract infection (UTI) is the most common bacterial infection in young infants, and the incidence of associated bacteremia has decreased in the recent decades.

View Article and Find Full Text PDF

BackgroundNeonatal early-onset disease caused by group B (GBS) is a leading cause of infant morbidity. Intrapartum antibiotic prophylaxis (IAP) is effective in preventing early-onset GBS disease, but there is no agreement on the optimal strategy for identifying the pregnant women requiring this treatment, and both risk-based prophylaxis (RBP) and GBS screening-based prophylaxis (SBP) are used.AimThe aim of this study was to evaluate the effect of SBP as a public health intervention on the epidemiology of early-onset GBS infections.

View Article and Find Full Text PDF
Article Synopsis
  • - The study evaluated the effectiveness of switching from intravenous to oral antibiotics (amoxicillin) for treating neonates with early-onset infection (EOI) and included data from 835 term-born neonates over two years.
  • - Results showed that 90% of neonates with probable infection successfully switched to oral therapy, with no readmissions due to infection and a shorter average hospital stay compared to those on intravenous therapy.
  • - Although oral therapy proved safe and beneficial for easing the treatment process, the overall use of antibiotics did not increase after implementing switch therapy.
View Article and Find Full Text PDF

Introduction: Febrile urinary tract infection is one of the most common bacterial infections in children. Currently, recommended antibiotic duration is 10 days. However, recent evidence suggests that 90%-95% of children with febrile urinary tract infections are afebrile and clinically improved 48-72 hours after treatment initiation.

View Article and Find Full Text PDF

Objective: To estimate the incidence of neonatal herpes simplex virus (HSV) infection and the number of neonates with suspected invasive bacterial infection (IBI) needed to treat (NNT) with acyclovir to ensure prompt treatment of invasive HSV infections.

Design: A nationwide population-based cohort study.

Setting: All neonatal and paediatric emergency departments in Denmark from 1 January 2010 to 31 December 2019.

View Article and Find Full Text PDF

Neonatal herpes simplex disease (HSV) is a rare but life-threatening infection associated with high rates of morbidity and mortality. Recent studies indicate that the incidence rate has continued to rise over the past decades, while the mortality remains unchanged. Early clinical suspicion of HSV and parenteral antiviral treatment of acute disease is essential for the prognosis.

View Article and Find Full Text PDF